Pay in 4 interest-free payments of $470.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
A2764 dihydrochloride is a selective inhibitor of TRESK (KCNK18) with an IC50 value of 11
The highest concentration
LOX regulates EGFR cell surface retention to drive tumour progression
10% Tween 80
A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways
Trabectedin - CAS# 114899-77-3 pone A2764 dihydrochloride is a selectiveTrabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug